CalciMedica CFO granted 67,728 stock options
CalciMedica, Inc. Chief Financial Officer Stephen Bardin received a grant of employee stock options covering 67,728 shares of common stock at an exercise price of $0.585 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CalciMedica, Inc. Chief Financial Officer Stephen Bardin received a grant of employee stock options covering 67,728 shares of common stock at an exercise price of $0.585 per share. Beginning April 1, 2026, 1/48th of the option shares vest in equal monthly installments over four years, with vesting starting only after the company files a Form S-8 for shares added under its 2023 Equity Incentive Plan.
Insider Trade Summary
Grant/Award: 67,728 shares
Grant/Award
1 txn
Insider
Bardin Stephen
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 67,728 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 67,728 contracts (Direct)
Footnotes (1)
- F1. Beginning April 1, 2026, 1/48th of the shares subject to the option vest in equal monthly installments over a four year period, provided, however, that no shares shall vest until the filing of the Company's registration statement on Form S-8 covering the shares of Common Stock that were automatically added to the shares authorized for issuance under the Company's 2023 Equity Incentive Plan on January 1, 2026 pursuant to an annual "evergreen" provision.
Key Figures
Option grant size: 67,728 options
Exercise price: $0.585 per share
Post-transaction derivative holdings: 67,728 options
+2 more
5 metrics
Option grant size
67,728 options
Employee stock option grant to CFO Stephen Bardin
Exercise price
$0.585 per share
Strike price for newly granted options
Post-transaction derivative holdings
67,728 options
Total options held after grant in this award
Vesting start date
April 1, 2026
1/48th of options vest monthly from this date, subject to S-8 filing
Expiration date
April 4, 2036
Option expiration for this grant
Key Terms
Employee Stock Option, Form S-8, 2023 Equity Incentive Plan, evergreen provision, +1 more
5 terms
Employee Stock Option financial
"security_title": "Employee Stock Option (Right to Buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Form S-8 regulatory
"no shares shall vest until the filing of the Company's registration statement on Form S-8"
A Form S-8 is a U.S. Securities and Exchange Commission registration that lets a public company set aside shares for employee benefit plans and stock-based compensation. Think of it as opening a dedicated account that authorizes the company to issue or reserve stock for workers and directors; it matters to investors because it enables share dilution when those awards are granted or exercised and signals how management is compensated and incentivized.
2023 Equity Incentive Plan financial
"under the Company's 2023 Equity Incentive Plan on January 1, 2026"
evergreen provision financial
"shares authorized for issuance under the Company's 2023 Equity Incentive Plan ... pursuant to an annual "evergreen" provision"
An evergreen provision is a clause in a financing or contract that automatically renews or replenishes the arrangement unless one party actively cancels it, like a subscription that keeps renewing each term. For investors it matters because it creates predictable, ongoing access to funding or ongoing contractual obligations — helping liquidity and planning — but can also hide long-term commitments or dilution risks if not reviewed.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CalciMedica (CALC) report for Stephen Bardin?
CalciMedica reported that CFO Stephen Bardin received an employee stock option grant for 67,728 shares of common stock at a $0.585 exercise price. This is a compensation-related award, not an open-market share purchase or sale.
What is the exercise price of Stephen Bardin’s new CalciMedica (CALC) stock options?
The employee stock options granted to CFO Stephen Bardin have an exercise price of $0.585 per share. This means he can buy CalciMedica common stock at $0.585 once the options vest and are exercised.
How do Stephen Bardin’s CalciMedica (CALC) options vest?
Beginning April 1, 2026, 1/48th of Stephen Bardin’s options vest in equal monthly installments over four years. However, no shares vest until CalciMedica files a Form S-8 covering additional shares under its 2023 Equity Incentive Plan.
When do Stephen Bardin’s CalciMedica (CALC) stock options expire?
Stephen Bardin’s employee stock options expire on April 4, 2036. He may exercise vested options at $0.585 per share any time before this expiration date, subject to the plan’s terms and company policies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
